A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2018-01-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare a needle-free treatment of hypoglycemia with nasal
glucagon (study drug) to a marketed glucagon administered by the intramuscular (IM) route, in
participants with type 1 diabetes mellitus (T1DM).